Koyfin Home > Directory > Health Care > Acceleron Pharma > Enterprise Value

Acceleron Pharma Enterprise Value Chart (XLRN)

Acceleron Pharma annual/quarterly Enterprise Value from 2013 to 2020.
  • Acceleron Pharma Enterprise Value for the quarter ending September 09, 2020 was $6,111m a -2.87% decrease of -175m year over year
  • Acceleron Pharma Enterprise Value for the last 12 months ending September 09, 2020 was $6,111m a -2.87% decrease of -175m year over year
  • Acceleron Pharma Annual Enterprise Value for 2020 was $6,111m a 0.00% decrease of 0m from 2019
  • Acceleron Pharma Annual Enterprise Value for 2020 was $6,111m a 3.05% increase of 186m from 2019
  • Acceleron Pharma Annual Enterprise Value for 2020 was $5,925m a -6.11% decrease of -362m from 2019
Other Valuation Metrics:
  • Acceleron Pharma Market Cap for the quarter ending March 03, 2018 was $1,776m a 33.91% increase of 602m year over year
  • Acceleron Pharma Price / Book for the quarter ending March 03, 2018 was 4.85 a -16.20% decrease of -0.78 year over year
View Chart On Koyfin

Quarterly XLRN Enterprise Value Data

09/2020$6,111m
09/2020$6,111m
09/2020$5,925m
09/2020$6,286m
09/2020$6,186m
09/2020$6,051m
09/2020$6,016m
09/2020$5,877m
09/2020$5,696m
09/2020$5,736m

Annual XLRN Enterprise Value Data

2020$6,111m
2020$6,111m
2020$5,925m
2020$6,286m
2020$6,186m
2020$6,051m
2020$6,016m
2020$5,877m
2020$5,696m
2020$5,736m